Moreover, it was found that ZNF582 low expression group has shorter OS (Overall Survival) and RFS (Recurrence-free Survival) than ZNF582 high expression group through combining the prognostic information of ccRCC patients in TCGA-KIRC (Fig. S1E). The gene discussed is ZNF582; the disease is nonpapillary renal cell carcinoma.